secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeyondSpring Inc. (BYSI)
CIK:        0001677940
Form:       8-K
Filed at:   2026-08-14T21:15:17+00:00
Accession:  0001171843-26-005557
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeyondSpring Q2 net loss $1.8M; ASCO data show 58% 24-month OS in post-ICI NSCLC
--------------------------------------------------------------------------------

- Q2 2026 net loss $1.8M vs $1.9M YoY; cash and short-term investments $6.5M at June 30, 2026.
- ASCO 2026 Phase 2 (n=47): median PFS 7.0 mo, ORR 18.2%, DCR 79.5%, 24-month OS 58.0%.
- Leadership effective July 1, 2026: Min Qiu CEO, Jen Majeti Vice Chairman, Na Li CFO.
- DUBLIN-4 planned confirmatory Phase 3: 442 patients, non-squamous EGFR-wild-type NSCLC post-ICI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326005557/0001171843-26-005557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677940/000117184326005557/f8k_081426.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-005557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer